Table of Contents
Sub: Outcome of the Board Meeting held on January 28, 2022
The Board of Directors of the Company at its meeting held on January 28, 2022 have considered and approved the Unaudited Consolidated and Standalone Financial Results of the Company for the Third Quarter and Nine Months ended December 31, 2021.
In this regard, please find enclosed herewith the following:
1. | Unaudited Consolidated and Standalone Financial Results of the Company for the Third Quarter and Nine Months ended December 31, 2021 (‘Financial Results’); Exhibit 99.1 |
2. | Limited Review Report for Financial Results from our Statutory Auditors, M/s S.R. Batliboi & Co. LLP, Chartered Accountants, in terms of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015; Exhibit 99.2 |
3. | A Press Release in respect to the Financial Results; and Exhibit 99.3 |
4. | Investor Presentation on the Financial Results. Exhibit 99. |
Further, we wish to inform you that the Board of Directors of the Company at its meeting held on January 28, 2022 have approved the following:
Jharsuguda, 430 KTPA Value Added Product (VAP) capacity expansion
430 KTPA (250 Billet and 180 PFA) capacity expansion at cost of ₹ 750 Crores which will improve Jharsuguda location VAP capacity to 87%. This project will also help cater the increased demand in the product and will improve the overall premium.
We request you to kindly take the above information on record.
Forward looking statement:
In addition to historical information, this Form 6K and the exhibits included herein contain forward-looking statements within the meaning of Section 27A of the Securities Act, of 1933, as amended, and Section 21E of the Securities Exchange Act, 1934, as amended. The forward looking statements contained herein are subject to risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements, Factors that might cause such a difference include, but are not limited to, those discussed in the section entitled “Special Note Regarding Forward-Looking Statements” in our Annual Report on Form 20F dated July 19, 2021. You are cautioned not to place undue reliance on these forward-looking statements, which reflect our management’s analysis only as of the date of the exhibits to this Form 6K. In addition, you should carefully review the other information in our Annual Report and other documents filed with the United States Securities and Exchange Commission (the “SEC”) from time to time. Our filings with the SEC are available on the SEC’website,www.sec.gov.
Exhibits